Wall Street Experts
ver. ZuMIgo(08/25)
PMV Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 2
EBIT TTM (mln): -79
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-19 |
-27 |
-35 |
-58 |
-77 |
-80 |
-85 |
EBIT Δ r/r |
0.0% |
41.0% |
31.2% |
66.8% |
32.2% |
4.0% |
6.6% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
-4 |
0 |
0 |
EBITDA (mln) |
-19 |
-26 |
-35 |
-58 |
-77 |
-79 |
-85 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
0 |
0 |
0 |
-0 |
0 |
-16 |
Zysk Netto (mln) |
-18 |
-25 |
-34 |
-58 |
-73 |
-69 |
-59 |
Zysk netto Δ r/r |
0.0% |
44.6% |
35.8% |
68.0% |
26.7% |
-5.9% |
-14.9% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
-0.56 |
-0.59 |
-0.77 |
-1.28 |
-1.61 |
-1.44 |
-1.14 |
EPS (rozwodnione) |
-0.56 |
-0.59 |
-0.77 |
-1.28 |
-1.61 |
-1.44 |
-1.14 |
Ilośc akcji (mln) |
31 |
43 |
45 |
45 |
46 |
48 |
52 |
Ważona ilośc akcji (mln) |
31 |
43 |
45 |
45 |
46 |
48 |
52 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |